Premium
Santarus, Inc. (MM) (SNTS)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Santarus, Inc. (NASDAQ:SNTS) today announced that on December 20, 2013 it filed an amendment (the “Amendment”) to its Solicitation/Recommendation Statement on Schedule 14D-9 (the “Schedule...
G-III Apparel Group Set to Join the S&P SmallCap 600 PR Newswire NEW YORK, Dec. 23, 2013 NEW YORK, Dec. 23, 2013 /PRNewswire/ -- G-III Apparel Group Ltd. (NASD:GIII) will replace Santarus...
Santarus, Inc. (NASDAQ: SNTS) today announced that it has begun patient enrollment in a multicenter, multinational, randomized, double-blind, placebo-controlled, multiple ascending dose...
Morgan & Morgan Announces the Investigation of Santarus, Inc. PR Newswire NEW YORK, Nov. 11, 2013 NEW YORK, Nov. 11, 2013 /PRNewswire/ -- Morgan & Morgan announces that it is...
Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. PR Newswire WAYNE, Pa., Nov. 11, 2013 WAYNE, Pa., Nov. 11, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating...
Harwood Feffer LLP Announces Investigation of Santarus, Inc. PR Newswire NEW YORK, Nov. 8, 2013 NEW YORK, Nov. 8, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating...
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests PR Newswire SAN DIEGO, Nov. 8, 2013 SAN DIEGO, Nov. 8, 2013 /PRNewswire/...
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Santarus, Inc. (“Santarus” or the “Company”) (NASDAQ:SNTS) concerning the proposed acquisition of the...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of Santarus Inc. (“Santarus” or the “Company”) (NASDAQ:SNTS) related to the...
Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”) is investigating the acquisition of Santarus, Inc. (NASDAQ: SNTS) by Salix Pharmaceuticals Ltd. Santarus and Salix...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
